FDA oversight of cell therapy clinical trials
- PMID: 22932219
- DOI: 10.1126/scitranslmed.3004131
FDA oversight of cell therapy clinical trials
Abstract
The U.S. Food and Drug Administration applies regulatory flexibility to balance benefits and risks to subjects in cell-therapy clinical trials.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
